Atsushi Aoyagi Selected Research

Ischemia

11/2019

Neuromuscular stimulation ameliorates ischemia-induced walking impairment in the rat claudication model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Atsushi Aoyagi Research Topics

Disease

8	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 10/2002
5	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2023 - 09/2015
4	Multiple System Atrophy 01/2018 - 09/2015
2	Parkinson Disease (Parkinson's Disease) 01/2018 - 09/2015
2	Infections 01/2018 - 09/2015
1	Prion Diseases (Transmissible Spongiform Encephalopathies) 01/2023
1	Down Syndrome (Down's Syndrome) 11/2022
1	Myalgia 07/2020
1	Tauopathies 02/2020
1	Ischemia 11/2019
1	Scrapie 01/2018
1	Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease) 01/2018
1	Chronic Traumatic Encephalopathy 12/2016
1	Synucleinopathies 09/2015
1	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 09/2015
1	Cognitive Dysfunction 09/2003

Drug/Important Bio-Agent (IBA)

9	PrionsIBA 01/2023 - 09/2015
4	SynucleinsIBA 01/2018 - 09/2015
4	Proteins (Proteins, Gene)FDA Link 01/2018 - 09/2015
4	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 10/2003 - 10/2002
4	AcetylcholinesteraseIBA 10/2003 - 10/2002
1	diazonaphthalenedisulfonic acid (NDS)IBA 01/2023
1	Protein Isoforms (Isoforms)IBA 01/2023
1	IsoenzymesIBA 07/2020
1	salicylhydroxamic acid (SHAM)IBA 11/2019
1	Donepezil (Aricept)FDA LinkGeneric 10/2003
1	Cholinergic Agents (Cholinergics)IBA 09/2003
1	4- ((1S)- methylamino- 3- (4- nitrophenoxy))propylphenyl N,N-dimethylcarbamateIBA 09/2003